Patient-reported outcomes for axitinib vs sorafenib in metastatic renal cell carcinoma: phase III (AXIS) trial

✍ Scribed by Cella, D; Escudier, B; Rini, B; Chen, C; Bhattacharyya, H; Tarazi, J; Rosbrook, B; Kim, S; Motzer, R

• Book ID: 120258735
• Publisher: Nature Publishing Group
• Year: 2013
• Tongue: English
• Weight: 501 KB
• Volume: 108
• Category: Article
• ISSN: 0007-0920
• DOI: 10.1038/bjc.2013.145